Funding

Elysium Therapeutics

United States · Biotech · Healthtech

Develops treatments to prevent and reverse overdoses caused by synthetic opioids

Visit elysiumrx.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
SAFE$7.5MParticipants not disclosed

Investors

No participants disclosed.

Coverage

Jan 28, 2026Elysium Therapeutics · SAFE

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourceselysiumrx.com ↗